Skip to main content
Cell & Gene Therapy Reagents

Home  —  Products  —  Cell & Gene Therapy Reagents

Product

Cell & Gene Therapy Reagents

Reagents supporting vector, cell-line and gene-therapy process development, built for the documentation rigour these programmes demand.

01 — Overview

What you are buying

Cell and gene therapy programmes are audited harder than almost anything else in biologics. We build these reagents documentation-first, because in this modality the paperwork is not an afterthought — it is the reason the material is usable.

  • Viral vector process development
  • Cell line development support
  • Gene therapy research programmes
  • Process characterization studies
Request a quote
Capabilities

Cell & gene therapy technologies.

From plasmid and viral-vector engineering to exosomes and cell secretomes — Theertha's advanced-modality platforms support gene-therapy and regenerative programmes, end to end.

Vector construction

Plasmid & construct engineering

Gene synthesis, cloning and assembly, and large-scale plasmid production and purification.

Vector purification

Platform purification

Affinity and ion-exchange chromatography and centrifugation, using cGMP-grade chemicals and process liquids.

Vector production

Suspension viral production

Customized media and suspension viral production, supported by cGMP-grade reagents and supplements.

Method development

Analytical characterization

Identity, purity and contamination assays, functional and physical parameters, and empty-capsid analysis.

Advanced modalities

Exosomes & cell secretomes

Exosome harvesting and cell-secretome exploration for precision-targeted, regenerative applications.

Regenerative

Stem-cell technologies

Harnessing stem-cell potential for regenerative medicine and tissue rejuvenation.

Capability detail

Every capability, in detail.

Each area of our cell & gene therapy support, from vector construction through advanced modalities.

01 — Capability

Plasmid Engineering

Gene synthesis, cloning and assembly, and large-scale plasmid production and purification — the DNA starting material for vector and cell-based programmes.

Enquire about Plasmid Engineering
THEERTHAPlasmid EngineeringVector constructionCAPABILITYFOR RESEARCH & DEVELOPMENT USE
02 — Capability

Platform Purification

Affinity and ion-exchange chromatography and centrifugation, using high-grade chemicals and process liquids, to purify vectors to a defined quality profile.

Enquire about Platform Purification
THEERTHAPlatform PurificationVector purificationCAPABILITYFOR RESEARCH & DEVELOPMENT USE
03 — Capability

Suspension Viral Production

Customized media and suspension viral production, supported by high-grade reagents and supplements, engineered to scale.

Enquire about Suspension Viral Production
THEERTHASuspension Viral ProductionVector productionCAPABILITYFOR RESEARCH & DEVELOPMENT USE
04 — Capability

Analytical Characterization

Identity, purity and contamination assays, functional and physical parameters, and empty-capsid analysis for advanced-modality products.

Enquire about Analytical Characterization
THEERTHAAnalytical CharacterizationMethod developmentCAPABILITYFOR RESEARCH & DEVELOPMENT USE
05 — Capability

Exosomes & Secretomes

Exosome harvesting and cell-secretome exploration for precision-targeted, regenerative applications.

Enquire about Exosomes & Secretomes
THEERTHAExosomes & SecretomesAdvanced modalitiesCAPABILITYFOR RESEARCH & DEVELOPMENT USE
06 — Capability

Stem-cell Technologies

Harnessing stem-cell potential for regenerative medicine and tissue rejuvenation.

Enquire about Stem-cell Technologies
THEERTHAStem-cell TechnologiesRegenerative medicineCAPABILITYFOR RESEARCH & DEVELOPMENT USE

Vial imagery is an illustrative representation of Theertha capability, not a finished commercial product.

Enquiry

Need a custom specification?

Most of what we supply is programme-specific. Send us the requirement and we will confirm feasibility, timeline and price.